Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease
NCT02248181
·
clinicaltrials.gov ↗
COMPLETED
Status
442
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Pramipexole
Sponsor
Boehringer Ingelheim